Advancing Cancer Care: The Rise of CAR T Cell Immunotherapy

Tue, 30 Dec 2025 10:42:07 +0000

Chimeric Antigen Receptor (CAR) T cell therapy has revolutionized cancer treatment by reprogramming a patient’s own T cells to recognize and attack malignant cells. Unlike traditional therapies, CAR T cells provide targeted, long-lasting responses by focusing on specific tumor antigens. With increasing clinical adoption and ongoing innovation, the Chimeric Antigen Receptor T Cells Market has become a central focus for researchers, healthcare providers, and industry stakeholders.